Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
amgen
astrazeneca
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
2
×
finch therapeutics
indiana blog main
indiana top stories
life sciences
microbiome
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pfizer
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
allergan
allergan aesthetics
alzheimer's disease
anemia
What
bio
roundup
acquisitions
august
biggest
biotech
build
busy
buy
ceo
company’s
daniel
days
debut
decisions
devices
drug
drugs
dyne’s
fda
gilead
legacy
microbiome
moves
news
nods
openly
opioid
o’day
past
pipeline
regulatory
sarepta’s
sciences
scores
seagen
seven
shkreli’s
slow
spoken
Language
unset
2
×
Current search:
pfizer
×
abbvie
×
" eli lilly "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More